Amyloid β-Protein 10-20 is widely used in research focused on Alzheimer's disease. It serves as a peptide fragment to study the aggregation and neurotoxicity of amyloid-β, which is a key factor in the progression of the disease. Researchers utilize this peptide to investigate mechanisms of plaque formation, test potential therapeutic compounds, and explore methods to inhibit amyloid aggregation. It is also employed in developing and validating diagnostic tools for detecting early stages of Alzheimer's. Additionally, it aids in understanding the structural and functional properties of amyloid-β peptides in neurodegenerative disorders.